Original article excerpt
Server-side extracted preview paragraphs from the original source.
GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
Bringing greater intelligence grounded in real scientific workflows for the life sciences industry.
We’re introducing a new model update to our GPT‑Rosalind series purpose-built for life sciences research at enterprise scale. It combines GPT‑5.5’s agentic coding and tool-use capabilities with stronger model intelligence in core drug-discovery domains such as medicinal chemistry and genomics, while advancing performance across broader life sciences analysis, design, and experimental workflows.
